The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 4,863 | 199,400 | SH | SOLE | 199,400 | 0 | 0 | ||
ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 17,957 | 2,232,857 | SH | SOLE | 2,232,857 | 0 | 0 | ||
ACCELERON PHARMA INC | COM | 00434H108 | 2,343 | 18,672 | SH | SOLE | 18,672 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 379 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ALBIREO PHARMA INC | COM | 01345P106 | 3,905 | 111,000 | SH | SOLE | 111,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,226 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 1,314 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 366 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | ||
ANGION BIOMEDICA CORP | COM | 03476J107 | 1,938 | 60,615 | SH | SOLE | 60,615 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 506 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 246 | 9,000 | SH | SOLE | 9,000 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047607 | 1,500 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 1,155 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
ASPIRA WOMENS HEALTH INC | COM | 04537Y109 | 579 | 103,104 | SH | SOLE | 103,104 | 0 | 0 | ||
AZIYO BIOLOGICS INC | COM | 05479K106 | 288 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 316 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BIODESIX INC | COM | 09075X108 | 14,596 | 1,104,953 | SH | SOLE | 1,104,953 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 4,190 | 12,100 | SH | SOLE | 12,100 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | COM | G11196105 | 971 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 2,367 | 74,000 | SH | SOLE | 74,000 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 53,196 | 796,106 | SH | SOLE | 796,106 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 402 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 84 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CONTINENTAL RESOURCES INC | COM | 212015101 | 1,468 | 38,600 | SH | SOLE | 38,600 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 880 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 1,100 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 1,162 | 45,114 | SH | SOLE | 45,114 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 198 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 373 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
EQUITRANS MIDSTREAM CORPORATIO | COM | 294600101 | 1,132 | 133,050 | SH | SOLE | 133,050 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 3,352 | 314,143 | SH | SOLE | 314,143 | 0 | 0 | ||
G1 THERAPEUTICS INC | COM | 3621LQ109 | 878 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 1,672 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
HOOKIPA PHARMA INC | COM | 43906K100 | 183 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,252 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
INARI MEDICAL INC | COM | 45332Y109 | 653 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 208 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 958 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 2,374 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM | G5269C101 | 279 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
LAIRD SUPERFOOD INC | COM | 50736T102 | 418 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
MASIMO CORP | COM | 574795100 | 1,940 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 1,236 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 7,805 | 80,200 | SH | SOLE | 80,200 | 0 | 0 | ||
OVINTIV INC | COM | 69047Q102 | 1,076 | 34,200 | SH | SOLE | 34,200 | 0 | 0 | ||
PIONEER NATURAL RESOURCES CO | COM | 723787107 | 618 | 3,800 | SH | SOLE | 3,800 | 0 | 0 | ||
PROGENITY INC | COM | 74319F107 | 964 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
PROGYNY INC | COM | 74340E103 | 885 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 449 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 1,555 | 30,247 | SH | SOLE | 30,247 | 0 | 0 | ||
QUIDEL CORP | COM | 74838J101 | 7,647 | 59,684 | SH | SOLE | 59,684 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 318 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203101 | 1,000 | 876,899 | SH | SOLE | 876,899 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 505 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 582 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
THERAPEUTICSMD INC | COM | 88338N107 | 119 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 826 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
TURNING POINT THERAPEUTICS INC | COM | 90041T108 | 624 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 3,229 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,721 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 424 | 12,300 | SH | SOLE | 12,300 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 426 | 8,000 | SH | SOLE | 8,000 | 0 | 0 |